Berenberg Bank analyst Luisa Hector maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £16.00.
In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...
Stocks in London are set to open lower on Tuesday, with a eurozone inflation reading, and US data in focus. Both batches of data will be scrutinised for what they could mean for the European Central ...
GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would ...
Shares of NYSE GSK opened at $33.43 on Friday. The company has a debt-to-equity ratio of 0.98, a current ratio of 0.81 and a quick ratio of 0.53. GSK has a 1-year low of $32.83 and a 1-year high ...
Previously head of GSK’s consumer health division, Walmsley joined the company in 2010 after spending 17 years at L’Oreal. Witty has been in charge of GSK since 2008 and is paid nearly £1.1 ...
Family of 2-year-old girl files lawsuit against DCYF and a Puyallup daycare in relation to her death
PARKLAND, Wash. — The family of a 2-year-old girl killed by her mother's boyfriend is now suing Washington state and the daycare the young girl attended. The lawsuit alleges more could have been ...
“I don’t want to speak about the details of what we discussed during that dinner because I want to respect the privacy, but we developed a good relation ... uptake. GSK’s Arexvy, which ...
GSK has acquired exclusive global rights to progress the clinical development and commercialisation of GSK’227. Credit: MAXSHOT.PL/Shutterstock. GlaxoSmithKline (GSK)’s B7-H3-targeted antibody-drug ...
G.T. consults for BMS, Genentech, GSK and Relation Tx, and serves on the scientific advisory board of Variant Bio. Jobs Postdoctor in tumor immunity ...
Credit: GSK Jesduvroq is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor. The product was discontinued for business reasons and not for any safety or effectiveness issues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback